WOCKPHARMA2,219.90

Wockhardt Ltd.

· Pharma & Health
₹ CrorePeersBIOCONSYNGENEASTERDMGLANDPPLPHARMACOHANCELALPATHLABNATCOPHARMMcap ₹35,962 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation223.0217.0227.0
+ Impairment Loss / (Reversal)79.00.00.0
+ Finance Costs305.0254.0213.0
+ Interest Income-6.0-16.0-5.0
+ Fair Value (Gains) / Losses0.0-7.0-13.0
+ Share-based Payments1.01.04.0
+ Unrealised FX (Gain) / Loss-2.04.01.0
+ Other Non-cash Items77.02.028.0
Changes in Working Capital
+ Inventories8.0-69.0-112.0
+ Trade Receivables — Current142.0-66.021.0
+ Other Current Assets35.0-192.029.0
+ Other Current Liabilities-193.0-165.0-220.0
Cash from Operating Activities
Profit Before Tax (per I/S)-420.0-16.0238.0463.0
+ Total Adjustments (incl. Working Capital)669.0-37.0173.0
Cash from Operations (pre-tax)249.0-53.0411.0
+ Income Taxes Paid30.0-31.021.0
Cash from Operating Activities219.0-22.0390.0
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)59.094.0136.0
+ Disp of Fixed Assets66.010.050.0
+ Acq of Intangibles under Development0.0271.0228.0
+ Disp of Intangibles under Development-157.00.00.0
+ Acq of Investment Property0.0404.0-39.0
+ Interest Received — Investing3.016.05.0
+ Other Inflows / (Outflows) — Investing10.0-40.029.0
Cash from Investing Activities-137.0-783.0-241.0
Cash from Financing Activities
+ Proceeds from Issue of Shares467.0982.00.0
+ Proceeds from Borrowings549.0728.0737.0
+ Repayment of Borrowings406.01,067.0525.0
+ Payment of Lease Liabilities79.070.071.0
+ Other Inflows / (Outflows) — Financing-197.0-164.0-195.0
Cash from Financing Activities334.0409.0-54.0
Net Changes in Cash (pre-FX)416.0-396.095.0
+ Effect of FX Rate Changes on Cash-1.03.010.0
Net Changes in Cash415.0-393.0105.0
Closing Cash505.0
Reference Items
EBITDA39.0393.0652.0772.0
EBITDA Margin %1.3913.0519.3321.66
Free Cash Flow (CFO − Capex)160.0-116.0254.0254.0
Free Cash Flow to Equity-369.0520.0
Free Cash Flow per Basic Share9.88-7.1615.6815.68
Price to Free Cash Flow141.58
Cash Flow to Net Income-0.460.391.96
Cash Paid for Taxes30.0-31.021.0
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.